Diamyd Medical AB | Income Statement
Fiscal year is September-August. All values SEK Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
100.00
443.00
513.00
757.00
922.00
Cost of Goods Sold (COGS) incl. D&A
8,819.00
11,700.00
12,848.00
13,202.00
13,535.00
Gross Income
8,719.00
11,257.00
12,335.00
12,445.00
12,613.00
SG&A Expense
4,275.00
-
-
-
-
EBIT
13,097.00
16,722.00
22,021.00
18,665.00
25,484.00
Unusual Expense
-
-
-
13,543.00
-
Non Operating Income/Expense
65.00
10.00
624.00
200.00
103.00
Pretax Income
12,633.00
16,034.00
21,397.00
32,008.00
25,555.00
Consolidated Net Income
12,633.00
16,034.00
21,397.00
32,008.00
25,555.00
Net Income
12,633.00
16,034.00
21,397.00
32,008.00
25,555.00
Net Income After Extraordinaries
12,633.00
16,034.00
21,397.00
32,008.00
25,555.00
Net Income Available to Common
12,633.00
16,034.00
21,397.00
32,008.00
25,555.00
EPS (Basic)
0.79
0.63
0.79
1.14
0.70
Basic Shares Outstanding
15,873.30
24,980.90
25,983.60
28,340.60
33,783.50
EPS (Diluted)
0.80
0.64
0.82
1.13
0.76
Diluted Shares Outstanding
15,873.30
24,980.90
25,983.60
28,340.60
33,783.50
EBITDA
12,942.00
16,614.00
21,995.00
18,559.00
25,378.00
Other Operating Expense
103.00
5,465.00
9,686.00
6,220.00
12,871.00
Non-Operating Interest Income
399.00
698.00
-
-
32.00
About Diamyd Medical AB
View Profile
